Everything you need to know about The Real Cost of Untreated Depression — and How TMS Changes the Math — how it works, what it costs, and how to find a provider who actually knows what they're doing.
The TMS Patient Buyer's Guide
Everything to know before your first consult — questions to ask, what to expect, and how to compare providers.
When patients hesitate about TMS, the reason is usually cost: even with insurance, a full course can mean real out-of-pocket money, and without insurance it’s thousands of dollars. That concern deserves a serious answer, not a brush-off.
Here’s the serious answer: untreated depression is dramatically more expensive. Not metaphorically — financially. The research on depression’s economic burden is extensive, and it reframes the treatment decision entirely.
What untreated depression actually costs
Lost earnings dwarf treatment costs. Depression’s largest economic impact isn’t medical bills — it’s work. Depression is a leading cause of disability worldwide, and its workplace cost comes in two forms: absenteeism (missed days) and presenteeism (being present but functioning at a fraction of capacity). Studies of the U.S. economic burden of major depression put workplace costs at roughly half of the total burden, with the average affected worker losing weeks of productive time per year. For an individual, a conservative estimate — a 20% productivity reduction on a $60,000 salary — is $12,000 per year, every year the episode persists.
Careers compound the loss. Depression during working years doesn’t just cost current income; it costs promotions not pursued, jobs lost, businesses not started. Treatment-resistant episodes lasting years land during peak earning decades. This compounding is invisible on any bill, and it’s the largest number in the ledger.
Medical costs multiply. People with untreated depression use more healthcare across the board — more primary care visits, more ER visits, worse outcomes for comorbid conditions. Depression roughly doubles the risk of developing cardiovascular disease and worsens the course of diabetes and chronic pain. Health plans consistently find that members with depression cost about twice as much in total medical spend as matched members without it — most of it not psychiatric care.
The cost of failed treatment cycles. Treatment-resistant depression has its own price tag: years of medication trials at $20–$500/month each, quarterly psychiatry visits, therapy, and the opportunity cost of the months each failed trial consumes. Patients often spend more across five years of unsuccessful medication cycling than a TMS course costs — while remaining depressed.
The human costs that resist pricing. Relationships, parenting capacity, and — at the extreme — suicide risk. We won’t put dollar figures on these, but any honest accounting acknowledges they exist and that they dwarf everything above.
Now the treatment side of the ledger
A full TMS course in 2026 costs roughly $6,000–$12,500 cash, and far less out of pocket with insurance — typically $500–$2,500 depending on plan design (full cost breakdown here). Most commercial insurers and Medicare cover it for treatment-resistant depression, defined as failing two to four medications — criteria that describe exactly the patients stuck in the expensive cycle above. (See our insurance guides and Aetna-specific walkthrough.)
Against those numbers:
- TMS response rates run 50–60% in treatment-resistant patients, with roughly a third reaching remission — the 2026 data here.
- Responders who return to even 80% of normal function on a $60,000 income recover the entire cash cost of treatment in months of restored productivity.
- Durability is real: most responders maintain gains at one year, extendable with maintenance sessions.
The expected-value math is lopsided. Even at a 50% response rate, the downside of trying TMS is bounded (the cost of the course), while the downside of not trying it is unbounded (additional years of the burden above).
”But what if it doesn’t work for me?”
A fair objection — no honest analysis ignores the 40–50% who don’t respond to a first course. Three things temper it:
- You learn something valuable either way. Non-response to one protocol informs the next step: different targeting, accelerated protocols, or other interventions. It’s a decision tree, not a dead end.
- Partial response has real value. Many “non-responders” by the 50%-improvement definition still improve meaningfully.
- Predictors are improving. Shorter current episodes and less medication resistance predict better outcomes — reasons to act sooner, not later. See what affects TMS success.
The uncomfortable conclusion
The rational time to treat resistant depression aggressively is early — before the compounding costs accumulate, while the episode is shorter (and more responsive), and while careers and relationships are intact. The most expensive strategy available is the most common one: waiting years while cycling through marginal medication adjustments.
If you’ve failed two or more antidepressants, you likely already qualify for insurance-covered TMS. The next step costs nothing: a consultation. Find a clinic near you, learn what a course actually involves, and run your own numbers.
Frequently asked questions
Is TMS worth it if I have to pay cash?
Run the math on your own situation: your income, your episode length so far, your medical spend. For most working adults, a responding course pays for itself within a year. Many clinics offer payment plans — patients compare real quotes in our community forum.
Does insurance really cover TMS now?
Yes — Medicare and nearly all major commercial insurers cover TMS for treatment-resistant MDD with prior authorization. Denials are commonly overturned on appeal with proper documentation; see the appeals guide.
What if I can’t take six weeks of daily appointments?
Sessions take under an hour including check-in, and theta burst protocols cut chair time to minutes. Most patients work full-time through treatment — see going back to work during TMS.
